Botulinum Toxin A Therapy In Early Post-Stroke Spasticity: Providing A Wider Treatment AvenueMaria Anna Lorrane P Gozum and Raymond L Rosales*
Department of Neurology and Psychiatry, University of Santo Tomas, Manila, Philippines
- *Corresponding Author:
- Raymond L. Rosales
Department of Neurology and Psychiatry
University of Santo Tomas, Manila, Philippines
E-mail: [email protected] / [email protected]
Received date: April 15, 2016; Accepted date: May 18, 2016; Published date: May 25, 2016
Citation: Gozum MALP, Rosales RL (2016) Botulinum Toxin A Therapy in Early Poststroke Spasticity: Providing a Wider Treatment Avenue. Int J Neurorehabilitation 3:207. doi:10.4172/2376-0281.1000207
Copyright: © 2016 Gozum MALP, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
The use of Botulinum toxin type A (BoNT) to address spasticity has been established over the years, and recently considered first line treatment in chronic post stroke patients. With its promising results, BoNT is now being combined with early neurorehabilitation to treat post-stroke spasticity in order to address the various neuromuscular and biomechanical impairments, contracture prevention, dystonia, associated reactions and pain. The beneficial effects of BoNT as an adjunct to early stroke rehabilitation, in contrast to customary physical therapy alone, is the case in point of this review, so as to suggest another complementary treatment avenue in rehabilitation care.